PATENT CLAIM ANALYSIS

Application Number: 15775871
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "080000"]

Abstract:
The present invention relates to Spirocyclic Pyridotriazine Derivatives of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, B, X, Y, R 1 , R 2  and R 16  are as defined herein. The present invention also relates to compositions comprising at least one Spirocyclic Pyridotriazine Derivative, and methods of using the Spirocyclic Pyridotriazine Derivatives for treating or preventing HIV infection in a subject.

Claim (Index 19):
The pharmaceutical composition of  claim 14 , further comprising one or more additional therapeutic agents selected from raltegravir, lamivudine, abacavir, ritonavir, dolutegravir, arunavir, atazanavir, emtricitabine, tenofovir, elvitegravir, rilpivirine and lopinavir.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15775966', '16061369', '15105376', '15560896', '15575433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7905853637151388
- 35 USC 102 Novelty (BERT): 0.5927670392757517
- Combined Prediction Score: 0.7708035312712
- Mean Citation Score: 452.614154
- Max Citation Score: 491.0582
- Similarity Product: 463.61069181990615

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test